LLY
Eli Lilly and Company
1,151.00$
-1.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.7% | 14.9% | 22.9% | 28.1% | 25.7% | 21.7% | 26.5% | 25.6% | 24.8% | 12.4% | 19.6% | 25.8% | |
| 7.0% | 7.2% | 7.1% | 7.8% | 7.5% | 5.5% | 5.4% | 5.5% | 5.3% | 4.5% | 3.9% | 3.1% | |
| 0.8% | 1.1% | 1.2% | 1.4% | 1.3% | 1.4% | 1.3% | 1.2% | 1.3% | 1.8% | 1.4% | 1.0% | |
| 2.6% | -0.7% | 5.2% | 5.2% | 14.2% | 2.9% | -1.1% | 4.1% | -2.3% | – | – | – | |
| 2.5% | -5.7% | -2.3% | 16.0% | -11.1% | -7.6% | -3.0% | -3.6% | -0.1% | -9.0% | -12.0% | -12.4% | |
| 8.0% | 8.1% | 5.1% | 10.8% | 14.0% | 6.1% | 8.3% | 6.6% | 8.7% | 21.7% | 18.7% | 12.0% | |
| -19.9% | 0.1% | -14.8% | -18.9% | 8.9% | -36.2% | -9.2% | -10.1% | -13.2% | -21.0% | -20.7% | -16.8% | |
| 10.7% | 10.7% | 10.2% | 11.0% | 10.8% | 10.8% | 10.9% | 10.9% | 12.4% | 11.9% | 10.4% | 8.3% | |
| -4.1% | -3.8% | -2.8% | -1.5% | -19.3% | -19.7% | -2.0% | -4.4% | -5.3% | -2.2% | -5.6% | -6.3% | |
| 13.5% | -0.9% | 11.8% | 15.0% | -3.4% | 21.0% | 1.2% | 1.8% | -0.2% | 25.3% | 19.8% | 12.4% | |
| -0.8% | -14.6% | -2.6% | 0.7% | -27.5% | -10.4% | -12.8% | -14.6% | -18.9% | 10.2% | 2.7% | -3.4% | |
| 0.2% | -1.0% | 4.3% | 9.8% | 6.8% | -25.4% | 5.4% | 0.6% | -6.1% | 2.2% | 1.0% | 6.1% | |
| 14.7% | 6.7% | 17.7% | 17.3% | 11.7% | 15.6% | 18.2% | 19.0% | 16.1% | -9.2% | 0.9% | 13.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.